Showing 1 - 10 of 22
Background: Vaborem is a fixed dose combination of vaborbactam and meropenem with potent activity against target Carbapenem-resistant Enterobacterales (CRE) pathogens, optimally developed for Klebsiella pneumoniae carbapenemase (KPC). The study aims to evaluate the cost-effectiveness of Vaborem...
Persistent link: https://www.econbiz.de/10014489937
Background: This study is aimed at describing the epidemiological and economic burden that HCV will generate in the next few years in Italy. Furthermore, the impact that future anti-HCV treatments may have on the burden of disease was considered. The analysis has been developed over the period...
Persistent link: https://www.econbiz.de/10010742262
Persistent link: https://www.econbiz.de/10013198220
Background: This study is aimed at describing the epidemiological and economic burden that HCV will generate in the next few years in Italy. Furthermore, the impact that future anti-HCV treatments may have on the burden of disease was considered. The analysis has been developed over the period...
Persistent link: https://www.econbiz.de/10014148519
Persistent link: https://www.econbiz.de/10013407459
Persistent link: https://www.econbiz.de/10009301298
Persistent link: https://www.econbiz.de/10009327565
Persistent link: https://www.econbiz.de/10009255483
Purpose: This paper aims to estimate the delay or timely effects of the national vaccination strategy for COVID-19 on Italian gross domestic product (GDP). By adopting a knowledge management lens, the study highlights the importance of “time” for Italian recovery. Indeed, recovering an...
Persistent link: https://www.econbiz.de/10012812516
Persistent link: https://www.econbiz.de/10003115536